ITMI932193A0 - Composti ad attivita' antiistaminica per la loro preparazione e composizioni farmaceutiche che li contengono - Google Patents

Composti ad attivita' antiistaminica per la loro preparazione e composizioni farmaceutiche che li contengono

Info

Publication number
ITMI932193A0
ITMI932193A0 ITMI932193A ITMI932193A ITMI932193A0 IT MI932193 A0 ITMI932193 A0 IT MI932193A0 IT MI932193 A ITMI932193 A IT MI932193A IT MI932193 A ITMI932193 A IT MI932193A IT MI932193 A0 ITMI932193 A0 IT MI932193A0
Authority
IT
Italy
Prior art keywords
compounds
contain
preparation
pharmaceutical compositions
antihistaminic activity
Prior art date
Application number
ITMI932193A
Other languages
English (en)
Inventor
Roberto Pellicciari
Original Assignee
Erregierre Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erregierre Spa filed Critical Erregierre Spa
Priority to ITMI932193A priority Critical patent/IT1271417B/it
Publication of ITMI932193A0 publication Critical patent/ITMI932193A0/it
Priority to EP94115981A priority patent/EP0648759A1/en
Priority to CA002118188A priority patent/CA2118188A1/en
Priority to JP6275617A priority patent/JPH07267947A/ja
Publication of ITMI932193A1 publication Critical patent/ITMI932193A1/it
Application granted granted Critical
Publication of IT1271417B publication Critical patent/IT1271417B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ITMI932193A 1993-10-15 1993-10-15 Composti ad attivita' antiistaminica procedimento per la loro preperazione e composizioni farmaceutiche che li contengono. IT1271417B (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ITMI932193A IT1271417B (it) 1993-10-15 1993-10-15 Composti ad attivita' antiistaminica procedimento per la loro preperazione e composizioni farmaceutiche che li contengono.
EP94115981A EP0648759A1 (en) 1993-10-15 1994-10-11 Antihistaminic compounds, process for their preparation and pharmaceutical compositions containing them
CA002118188A CA2118188A1 (en) 1993-10-15 1994-10-14 Antihistaminic compounds, process for their preparation and pharmaceutical compositions containing them
JP6275617A JPH07267947A (ja) 1993-10-15 1994-10-14 抗ヒスタミン化合物とその製造プロセスおよび抗ヒスタミン化合物含有の薬剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI932193A IT1271417B (it) 1993-10-15 1993-10-15 Composti ad attivita' antiistaminica procedimento per la loro preperazione e composizioni farmaceutiche che li contengono.

Publications (3)

Publication Number Publication Date
ITMI932193A0 true ITMI932193A0 (it) 1993-10-15
ITMI932193A1 ITMI932193A1 (it) 1995-04-15
IT1271417B IT1271417B (it) 1997-05-28

Family

ID=11367038

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI932193A IT1271417B (it) 1993-10-15 1993-10-15 Composti ad attivita' antiistaminica procedimento per la loro preperazione e composizioni farmaceutiche che li contengono.

Country Status (4)

Country Link
EP (1) EP0648759A1 (it)
JP (1) JPH07267947A (it)
CA (1) CA2118188A1 (it)
IT (1) IT1271417B (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165274B1 (es) 1999-06-04 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
GB0018691D0 (en) * 2000-07-28 2000-09-20 Rolabo Sl Process
ES2172436B1 (es) 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
ES2201907B1 (es) 2002-05-29 2005-06-01 Almirall Prodesfarma, S.A. Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
US20130237709A1 (en) * 2012-03-02 2013-09-12 Chemelectiva S.R.L. Intermediates useful for the synthesis of fexofenadine, processes for their preparation and for the preparation of fexofenadine
ITMI20132039A1 (it) * 2013-12-06 2015-06-07 Dipharma Francis Srl "metodo per la preparazione di intermedi sintetici"

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE194913T1 (de) * 1992-05-11 2000-08-15 Merrell Pharma Inc Verwendung von terfenadin-derivaten als antihistaminika in leberkranken patienten

Also Published As

Publication number Publication date
IT1271417B (it) 1997-05-28
CA2118188A1 (en) 1995-04-16
EP0648759A1 (en) 1995-04-19
ITMI932193A1 (it) 1995-04-15
JPH07267947A (ja) 1995-10-17

Similar Documents

Publication Publication Date Title
FI944832A (fi) Farmaseuttinen koostumus
ITMI930582A0 (it) Composizione farmeceutiche ad attivita' analgesica
ITMI931325A0 (it) Composizione farmaceutica ad attivita' analgesica
ITMI932540A0 (it) Composizione farmaceutica
ITMI932193A0 (it) Composti ad attivita' antiistaminica per la loro preparazione e composizioni farmaceutiche che li contengono
LV10579A (lv) Farmaceitiska kompozicija
IT1243702B (it) Composti ad attivita' nootropa, procedimento per la loro preparazione e relative composizioni farmaceutiche
ITMI911335A0 (it) Composti ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI911298A0 (it) Composti ad attivita' anticolinesterasi. procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI931806A0 (it) Composti inibitpri di acil enzima-a-colesterolo-o-acil transferasi ad attivita' terapeutica , loro uso e composizioni farmaceutiche che li contengono
ITMI930453A1 (it) Composizione farmaceutica avente attivita' antiasmatica
IT1200470B (it) Composti ad attivita' antibatterica,loro preparazione e composizioni farmaceutiche relative
ITMI913511A0 (it) Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI950880A0 (it) Composti eterociclici composizioni farmaceutiche che li comprendono e procedimento per la loro preparazione
ITMI921252A0 (it) Composizione farmaceutica ad attivita' antitosse
IT8822258A0 (it) Composti ad attivita' spasmolitica, loro preparazione e relative composizioni farmaceutiche
ITMI911380A0 (it) Composti ad attivita' antiinfiammatoria e formulazioni farmaceutiche che li contengono
IT1276707B1 (it) Composizioni farmaceutiche ad attivita' analgesica
IT1219429B (it) Composizioni farmaceutiche ad attivita' antiprolattinica
ITMI913398A0 (it) Derivati dell'eserolina ad attivita' anticolinesterasica procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1269316B (it) Composizioni farmaceutiche ad attivita' antitossica
ITMI912238A0 (it) Composti ad attivita' mucolitica e antisettica procedimento per la loro preparazione e relative composizioni farmaceutiche
ITMI911653A0 (it) Derivati dell'eseridina ad attivita' amticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI913512A0 (it) Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI911444A0 (it) Derivati dell'eserolina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971030